Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Comtripsy 6.14mg/15mg Tablet

Prescription Icon
Prescription Required

Marketer

Intas Pharmaceuticals Ltd

Salt Composition

Tipiracil (6.14mg) + Trifluridine (15mg)

Overview Comtripsy 6.14mg/15mg Tablet

OncoComb 6.14mg/15mg tablets combine two agents to combat metastatic colorectal cancer. This medication inhibits or reduces the proliferation of cancerous cells. Administer OncoComb 6.14mg/15mg with food, consistently at the same time daily for optimal efficacy. Dosage and frequency are determined by your physician based on your specific condition and may be adjusted. Strictly adhere to your doctor's prescribed regimen; deviations or overdoses can lead to severe adverse reactions. Therapeutic effects might not be apparent for weeks or months; discontinue use only under medical direction. Frequent side effects include anemia, neutropenia, weariness, nausea, thrombocytopenia, appetite loss, diarrhea, emesis, and pyrexia. Report any bothersome side effects to your doctor. Regular blood tests monitor blood cell counts and hepatic function. Inform your healthcare provider of all medications you are taking, as interactions are possible. This medication is contraindicated during pregnancy and lactation. Utilizing effective contraception is crucial for both partners throughout treatment to prevent conception.

Uses of Comtripsy 6.14mg/15mg Tablet

Colorectal cancer

Major Benefits of Comtripsy 6.14mg/15mg Tablet:

Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Comtripsy 6.14mg/15mg Tablet whole; do not fracture, pulverize, or chew it. Administer this medication with a meal.

Common Side effects of Comtripsy 6.14mg/15mg Tablet:

  • Anemia (low number of red blood cells)
  • Decreased white blood cell count (neutrophils)
  • Fatigue
  • Nausea
  • Low blood platelets
  • Decreased appetite
  • Diarrhea
  • Fever
  • Vomiting

How to use Comtripsy 6.14mg/15mg Tablet:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment duration. Ingest the Comtripsy 6.14mg/15mg Tablet whole; avoid chewing, crushing, or fracturing it. Consume this medication with food.

How Comtripsy 6.14mg/15mg Tablet works:

The dual-action oncology tablet, Comtripsy 6.14mg/15mg, comprises two anti-cancer agents. Trifluridine inhibits DNA replication, thereby halting cancer cell proliferation. Concurrently, tipiracil extends trifluridine's lifespan within the body.

SAFETY ADVICE

AlcoholAlcoholCONSULT YOUR DOCTOR

Alcohol consumption alongside Comtripsy 6.14mg/15mg Tablet may pose safety risks; seek medical advice before combining them.

PregnancyPregnancyCONSULT YOUR DOCTOR

Using Comtripsy 6.14mg/15mg tablets during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the benefits against potential risks prior to prescribing. Patient consultation with their doctor is advised.

Breast feedingBreast feedingCAUTION

Maternal use of Comtripsy 6.14mg/15mg tablets necessitates caution while breastfeeding. Breastfeeding is advised against until the mother's treatment concludes and the medication is fully cleared from her system.

DrivingDrivingCONSULT YOUR DOCTOR

Driving ability may be affected by Comtripsy 6.14mg/15mg Tablet, though this is unconfirmed. Refrain from driving if concentration or reaction time is impaired.

KidneyKidneySAFE IF PRESCRIBED

Patients with kidney disease can safely take Comtripsy 6.14mg/15mg tablets without any required dose modification.

LiverLiverSAFE IF PRESCRIBED

Comtripsy 6.14mg/15mg tablets can be administered to patients with hepatic impairment without modification to the prescribed dosage.

What if you forget to take Comtripsy 6.14mg/15mg Tablet :

Should you forget a Comtripsy 6.14mg/15mg Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Comtripsy 6.14mg/15mg Tablet

LabelValue
Developing Habits No.
Treatment Category Cancer Therapeutics

FAQs on Comtripsy 6.14mg/15mg Tablet

Comtripsy 6.14mg/15mg Tablet may harm a developing fetus. Avoid pregnancy (for both men and women) during treatment and for six months afterward. Discuss contraception with your doctor before starting treatment.
Breastfeeding is not recommended during treatment with Comtripsy 6.14mg/15mg Tablet and for 24 hours after the last dose.
Soluble fiber, found in foods like ripe bananas, oranges, boiled potatoes, white rice, yogurt, and oatmeal, can help alleviate diarrhea by absorbing excess fluid. To combat the dehydration diarrhea can cause, drink eight to ten glasses of water daily, supplementing with frequent sips of soup or juice.
Maintain your usual diet unless your doctor advises differently. Regular water intake is recommended to prevent dehydration. Consider frequent small, nutritious snacks instead of large meals, and hard candies or popsicles may help alleviate nausea and vomiting.
Continue this medication precisely as prescribed until your physician instructs otherwise. Regular imaging will monitor the tumor's response, with scheduling determined by your doctor.
Comtripsy 6.14mg/15mg Tablets reduce white blood cells and platelets, increasing your infection risk. Avoid contact with sick individuals. Contact your doctor promptly if you suspect an infection or develop fever, chills, or cough.
Low platelet counts can cause gum bleeding. Platelets are blood cells essential for blood clotting after injury.
Combating fatigue involves several strategies, including light exercise; however, it's crucial to consult your physician before starting any exercise program.
Comtripsy 6.14mg/15mg Tab...
3,078
MRP 3,750
17% off